Announcement • Jul 24
Mexan Limited Announces Board and Committee Changes, Effective July 22, 2026 Mexan Limited announced that Mr. Lun Yiu Kay Edwin had tendered his resignation as the chairman of the Company, an executive director of the Company, an authorised representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities, the chairman of the executive committee of the Company, the chairman of the nomination committee of the Company, and the member of the remuneration committee of the Company with effect from July 22, 2026 to concentrate on other business commitments. After the resignation of Mr. Lun, Ms. Chan Wai Yan, the independent non-executive director, had been appointed as the authorised representative of the Company with effect from July 22, 2026. Following the resignation of Mr. Lun, with effect from July 22, 2026, the composition of the board committees had been changed as follows: Mr. Law Hok Yu, the executive director, had been re-designated as the chairman of the Executive Committee; and Ms. Li Ching Yi, the independent non-executive director, had been re-designated as the chairman of the Nomination Committee. New Risk • Jul 09
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: HK$78.3m (US$9.99m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (21% average weekly change). Market cap is less than US$10m (HK$78.3m market cap, or US$9.99m). Minor Risk Significant insider selling over the past 3 months (HK$2.6m sold). Reported Earnings • Jul 02
Full year 2026 earnings released: HK$0.001 loss per share (vs HK$0.02 loss in FY 2025) Full year 2026 results: HK$0.001 loss per share (improved from HK$0.02 loss in FY 2025). Revenue: HK$44.1m (up 17% from FY 2025). Net loss: HK$2.14m (loss narrowed 95% from FY 2025). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. 
